Literature DB >> 11781423

Plasma exchange for severe attacks of CNS demyelination: predictors of response.

M Keegan1, A A Pineda, R L McClelland, C H Darby, M Rodriguez, B G Weinshenker.   

Abstract

The authors reviewed 59 consecutive patients treated with plasma exchange (PE) for acute, severe attacks of CNS demyelination at Mayo Clinic from January 1984 through June 2000. Most patients had relapsing-remitting MS (n = 22, 37.3%), neuromyelitis optica (NMO) (n = 10, 16.9%), and acute disseminated encephalomyelitis (n = 10, 16.9%). PE was followed by moderate or marked functional improvement in 44.1% of treated patients. Male sex (p = 0.021), preserved reflexes (p = 0.019), and early initiation of treatment (p = 0.009) were associated with moderate or marked improvement. Successfully treated patients improved rapidly following PE, and improvement was sustained.

Entities:  

Mesh:

Year:  2002        PMID: 11781423     DOI: 10.1212/wnl.58.1.143

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  135 in total

Review 1.  Acute disseminated encephalomyelitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

2.  Plasmapheresis: are bigger studies necessarily better?

Authors:  Brian Weinshenker
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

3.  Escalating immunotherapy of multiple sclerosis.

Authors:  Peter Rieckmann; Anthony Traboulsee; Virginia Devonshire; Joel Oger
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

4.  Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype.

Authors:  G Giovannoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-18       Impact factor: 10.154

Review 5.  Current understanding of the epidemiologic and clinical characteristics of optic neuritis.

Authors:  Masanori Nakazawa; Hitoshi Ishikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2021-05-22       Impact factor: 2.447

6.  Acute disseminated encephalomyelitisin the intensive care unit:clinical features and outcome of 20 adults.

Authors:  Romain Sonneville; Sophie Demeret; Isabelle Klein; Lila Bouadma; Bruno Mourvillier; Juliette Audibert; Stéphane Legriel; Francis Bolgert; Bernard Regnier; Michel Wolff
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

7.  Extensive acute disseminated encephalomyelitis in a young girl responding to intravenous methylprednisolone.

Authors:  Rajesh Verma; Tushar B Patil; Rakesh Lalla; Manoj Kumar
Journal:  BMJ Case Rep       Date:  2013-10-03

Review 8.  Treatment of acute relapses in multiple sclerosis.

Authors:  Regina Berkovich
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

Review 9.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

Review 10.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.